Skip to content

Mithridate: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Mithridate

BE 0802.360.343
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€139,695
2024 · -€181,061+€41,366
Equity
-€314,757
2024 · -€175,061-€139,695
Cash
€11,860
2024 · €23,486-€11,627
Balance sheet total
€164,214
2024 · €104,568+€59,646

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€73,542

    up €73,542 (+506.5%), from €14,520 to €88,062

  • Cash -€11,627

    down €11,627 (-49.5%), from €23,486 to €11,860

    mainly Net result for the year (-€139,695) and Receivables within one year (-€73,542)

  • Intangible fixed assets -€2,269

    down €2,269 (-3.4%), from €66,562 to €64,292

Equity and liabilities
  • Other debts +€199,229

    up €199,229 (+79.7%), from €250,030 to €449,259

  • Profit (loss) carried forward -€139,695

    down €139,695 (-77.2%), from -€181,061 to -€320,757

  • Trade debts +€10,408

    up €10,408 (+168.3%), from €6,184 to €16,592

  • Tax, wage and social debts -€9,901

    down €9,901 (-43.7%), from €22,677 to €12,776

    of which Remuneration and social security: -€7,061

Income statement
  • Gross operating margin +€82,759

    up €82,759, from -€30,867 to €51,892

  • Financial charges +€38,490

    up €38,490 (+8687.8%), from €443 to €38,933

  • Staff costs +€2,279

    up €2,279 (+1.5%), from €147,406 to €149,685

  • Depreciation +€757

    up €757 (+50.0%), from €1,512 to €2,269

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€181,061
Gross operating margin +€82,759
Staff costs -€2,279
Depreciation -€757
Other operating charges +€134
Financial income -€1
Financial charges -€38,490
Result 2025 -€139,695

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€11,627
Investment €0
Financing €0
Cash 2024 €23,486
Net result for the year -€139,695
Depreciation +€2,269
Receivables within one year -€73,542
Trade debts +€10,408
Tax, wage and social debts -€9,901
Other debts +€199,229
Accrued charges and deferred income -€395
Cash 2025 €11,860
Every line side by side 32 lines
Line Code 2024 2025 Change %
Total assets 20/58 €104,568 €164,214 +€59,646 +57.0%
Fixed assets 21/28 €66,562 €64,292 -€2,269 -3.4%
Intangible fixed assets 21 €66,562 €64,292 -€2,269 -3.4%
Current assets 29/58 €38,006 €99,921 +€61,915 +162.9%
Amounts receivable within one year 40/41 €14,520 €88,062 +€73,542 +506.5%
Trade receivables 40 €14,520 €88,062 +€73,542 +506.5%
Cash at bank and in hand 54/58 €23,486 €11,860 -€11,627 -49.5%
Total equity and liabilities 10/49 €104,568 €164,214 +€59,646 +57.0%
Equity 10/15 -€175,061 -€314,757 -€139,695 -79.8%
Contributions 10/11 €6,000 €6,000 = 0.0%
Profit (loss) carried forward 14 -€181,061 -€320,757 -€139,695 -77.2%
Amounts payable 17/49 €279,629 €478,970 +€199,341 +71.3%
Amounts payable within one year 42/48 €278,891 €478,627 +€199,736 +71.6%
Trade debts 44 €6,184 €16,592 +€10,408 +168.3%
Suppliers 440/4 €6,184 €16,592 +€10,408 +168.3%
Taxes, remuneration and social security 45 €22,677 €12,776 -€9,901 -43.7%
Taxes 450/3 €5,376 €2,536 -€2,840 -52.8%
Remuneration and social security 454/9 €17,301 €10,240 -€7,061 -40.8%
Other amounts payable 47/48 €250,030 €449,259 +€199,229 +79.7%
Accrued charges and deferred income 492/3 €738 €343 -€395 -53.5%
Remuneration, social security and pensions 62 €147,406 €149,685 +€2,279 +1.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,512 €2,269 +€757 +50.0%
Other operating charges 640/8 €834 €700 -€134 -16.1%
Gross operating margin 9900 -€30,867 €51,892 +€82,759
Operating profit (loss) 9901 -€180,619 -€100,762 +€79,857 +44.2%
Financial income 75/76B €1 €0 -€1 -100.0%
Recurring financial income 75 €1 €0 -€1 -100.0%
Financial charges 65/66B €443 €38,933 +€38,490 +8687.8%
Recurring financial charges 65 €443 €38,933 +€38,490 +8687.8%
Profit (loss) for the period before taxes 9903 -€181,061 -€139,695 +€41,366 +22.8%
Profit (loss) for the period 9904 -€181,061 -€139,695 +€41,366 +22.8%
Profit (loss) for the period to be appropriated 9905 -€181,061 -€139,695 +€41,366 +22.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.